| Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review JG Chiabrando, A Bonaventura, A Vecchié, GF Wohlford, AG Mauro, ... Journal of the American College of Cardiology 75 (1), 76-92, 2020 | 286 | 2020 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 181 | 2020 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 159 | 2021 |
| IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 147 | 2018 |
| Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ... Diabetes Care 40 (12), 1733-1738, 2017 | 119 | 2017 |
| Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with … GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ... Journal of cardiovascular pharmacology 77 (1), 49-60, 2021 | 73 | 2021 |
| Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo … PC Cremer, A Abbate, K Hudock, C McWilliams, J Mehta, SY Chang, ... The Lancet Rheumatology 3 (6), e410-e418, 2021 | 64 | 2021 |
| Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022 | 54 | 2022 |
| Role for anti-cytokine therapies in severe coronavirus disease 2019 LF Buckley, GF Wohlford, C Ting, A Alahmed, BW Van Tassell, A Abbate, ... Critical care explorations 2 (8), e0178, 2020 | 54 | 2020 |
| Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ... Clinical cardiology 41 (8), 1004-1008, 2018 | 50 | 2018 |
| Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow‐up: a subgroup analysis of high‐risk ACCORDION trial participants LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ... Diabetes, Obesity and Metabolism 20 (6), 1499-1502, 2018 | 45 | 2018 |
| Clinical presentation and outcomes of acute pericarditis in a large urban hospital in the United States of America A Vecchié, JG Chiabrando, MS Dell, A Bonaventura, AG Mauro, ... Chest 158 (6), 2556-2567, 2020 | 32 | 2020 |
| Alirocumab in acute myocardial infarction: results from the Virginia commonwealth university alirocumab response trial (VCU-AlirocRT) CR Trankle, G Wohlford, LF Buckley, D Kadariya, K Ravindra, R Markley, ... Journal of cardiovascular pharmacology 74 (3), 266-269, 2019 | 29 | 2019 |
| Metabolic modulation predicts heart failure tests performance D Contaifer Jr, LF Buckley, G Wohlford, NG Kumar, JM Morriss, ... PLoS One 14 (6), e0218153, 2019 | 28 | 2019 |
| Recent updates on the use of PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease DL Dixon, LG Pamulapati, JD Bucheit, EM Sisson, SR Smith, CJ Kim, ... Current atherosclerosis reports 21, 1-9, 2019 | 28 | 2019 |
| C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of … J Van Wezenbeek, JM Canada, K Ravindra, S Carbone, CR Trankle, ... Frontiers in cardiovascular medicine 5, 178, 2018 | 24 | 2018 |
| Acute effects of interleukin-1 blockade using anakinra in patients with acute pericarditis GF Wohlford, LF Buckley, A Vecchié, D Kadariya, R Markley, CR Trankle, ... Journal of cardiovascular pharmacology 76 (1), 50-52, 2020 | 23 | 2020 |
| Pharmacokinetics of L-triiodothyronine in patients undergoing thyroid hormone therapy withdrawal B Van Tassell, GF Wohlford IV, JD Linderman, S Smith, S Yavuz, F Pucino, ... Thyroid 29 (10), 1371-1379, 2019 | 21 | 2019 |
| IL-1 blockade in patients with heart failure with preserved ejection fraction BW Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, D Kadariya, ... Circ Heart Fail 11 (8), e005036, 2018 | 18 | 2018 |
| IL-1 blockade in patients with heart failure with preserved ejection fraction. Circ S Carbone, L Buckley, D Kadariya, MG Del Buono, H Billingsley, ... Heart Fail 11, e005036, 2018 | 18 | 2018 |
